[Reactive arthritis associated with Chlamydia trachomatis infection: Importance of screening and treating the partner].
J
J
Borges-Costa
D
D
Pacheco
F
F
Pereira
M
M
Marques-Gomes
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D016918:Arthritis, Reactive / Q000188:drug therapy / Q000209:etiology*; D001446:Balanitis / Q000209:etiology; D002584:Cervix Uteri / Q000382:microbiology; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000188:drug therapy; D002692:Chlamydia trachomatis / Q000302:isolation & purification*; D003235:Conjunctivitis, Inclusion / Q000209:etiology; D016358:Contact Tracing; D004318:Doxycycline / Q000627:therapeutic use; D005260:Female; D020022:Genetic Predisposition to Disease; D015796:HLA-B27 Antigen / Q000032:analysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use; D058566:Sacroiliitis / Q000188:drug therapy / Q000209:etiology; D012747:Sexual Partners; D013653:Tattooing; D014526:Urethritis / Q000209:etiology; D055815:Young Adult
D000900:Anti-Bacterial Agents; D015796:HLA-B27 Antigen; D007166:Immunosuppressive Agents; D004318:Doxycycline; D008727:Methotrexate